Apollo Hospitals Enterprise Limited appears to be a financially healthy company with a strong growth trajectory, evident from its revenue growth of 13.1% and earnings growth of 53.5%. The company's profitability metrics, such as ROE and profit margins, are decent, indicating efficient operations. However, the company's valuation seems stretched, with a trailing P/E of 69.43 and forward P/E of 85.86, suggesting that the stock may be overpriced. A concern is the high debt-to-equity ratio of 90.89, which may impact the company's financial flexibility. Overall, the company's growth prospects and profitability are strengths, but valuation and debt position are areas of concern.